Vendula Belackova
Biographic Data
| ID | 6094647 |
|---|---|
| NAME | Vendula Belackova |
| GIVEN NAMES | Vendula |
| FAMILY NAME | Belackova |
| SIGNATURE | BĚLÁČKOVÁ V |
| AFFILIATIONS | UNSW Sydney |
| ORCID | 0000-0002-1334-5425 |
| VERIFIED | Yes |
| TOTAL WORKS | 22 |
| TOTAL CITATIONS | 2 |
| WORKS AS AUTHOR | 22 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2015 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 1 |
The new EU Drugs Strategy
Outreach mpox vaccination at sex-on-premises venues in Sydney
Mpox outreach vaccination done in collaboration between nurses and LGBTQI+ peer-workers at SOPVs proved feasible, acceptable, and beneficial in terms of reaching people who may be out of area and not routinely engaged with sexual health services. Models of care that circumnavigate traditional geographic and local health service barriers should be considered during outbreaks, particularly those that build on established rapport within the communit…
Hydromorphone Hopes
Outcomes of a community sector model of reintegration for people with complex needs
The Optimus International Consensus Guidance for Monitoring User-Reported Outcomes of Opioid Maintenance Treatment
Opioid use disorder is a major cause of drug-related harm and mortality. These can be reduced by expanded access to evidence-based and highly effective opioid agonist maintenance treatment or therapy (OMT). There is a lack of consensus on how to assess opioid use disorder treatment outcomes, and key health outcomes are often omitted. We report the results of a Delphi study to produce service user- and public health–centred international consensus…
Getting “The whole picture”
BACKGROUND: Several jurisdictions have pursued reforms that regulate cannabis production and/or sale for adult (non-medical) use. Looking at outcomes of such reforms across multiple jurisdictions may help to identify outcomes that are inherent to non-criminal cannabis supply, as well as provide insight into the outcomes of specific regulation models. METHODS: We identified nine indicators of cannabis policy outcomes and aggregated them into three…
Bridging the evidence and the politics
Supervised Injectable Opioid Treatment (SIOT) targets people experiencing opioid dependence who have not benefited from existing treatments. In this population, SIOT has been demonstrated to be efficacious and effective, yet this modality of treatment has only been taken up in a few countries. In this commentary we describe the socio-political context and history to the recent establishment of an implementation trial of injectable hydromorphone i…
Ex-Ante Analysis of the Costs and Benefits of Legalizing Cannabis Markets in the Czech Republic
Cannabis is the most commonly used illicit drug worldwide. In countries with repressive drug policies, the costs of its prohibition plausibly outweigh the benefits. We conduct a cost–benefit analysis of cannabis legalization and regulation in the Czech Republic, taking into consideration alternative scenarios designed using parameters from the known effects of cannabis legalization in selected U.S. states, Canada, and Uruguay. Our analysis focuse…
Opioid Agonist Maintenance Treatment Outcomes—The Optimus International Consensus Towards Evidence-Based and Patient-Centred Care, an Interim Report
Non-medical opioid use is a major public health concern causing high mortality. While opioid agonist maintenance treatment (OMT) is a key life-saving intervention, there is (a) no international consensus on opioid treatment outcomes and (b) few opioid treatment outcome studies include key (public) health outcomes, such as overdose or HIV/hepatitis C. We report the rationale and study protocol for, and preliminary results of, an ongoing internatio…
Monitoring drug trends in the digital environment–New methods, challenges and the opportunities provided by automated approaches
How to ask about the use of new psychoactive substances to increase the validity of results in self‐report prevalence surveys
The Good, the Bad, and the Ugly Weed”
With proliferating efforts to regulate the quality of cannabis on legalized markets, and recent discussions about drug quality assessment by darknet buyers, it seems timely to explore definitions of the quality of cannabis among consumers. An inductive analysis of in-depth interviews with people who had used cannabis in the past 12 months was conducted, which focused on the respondents’ subjective definitions and assessments of the quality of can…
Beyond Safer Injecting”—Health and Social Needs and Acceptance of Support among Clients of a Supervised Injecting Facility
Health and social issues in aging populations of people who inject drugs (PWID) tend to aggregate, despite risky injecting practices decreasing with age. Identifying needs and avenues of support is becoming increasingly important. We described the health and social situation among clients of a long-running supervised injecting facility (SIF) in Sydney, Australia. An interviewer-administered survey ( n = 182) assessed current housing status, emplo…
Learning from the past, looking to the future - Is there a place for injectable opioid treatment among Australia’s responses to opioid misuse
Overview of “home” cultivation policies and the case for community-based cannabis supply
Interpreting the Czech drug decriminalization
The burgeoning recognition and accommodation of the social supply of drugs in international criminal justice systems
Consumer agency in cannabis supply – Exploring auto-regulatory documents of the cannabis social clubs in Spain
Assessing the concordance between illicit drug laws on the books and drug law enforcement
Online test purchased new psychoactive substances in 5 different European countries
Qualitative research in Spanish cannabis social clubs
Should I Buy or Should I Grow?” How drug policy institutions and drug market transaction costs shape the decision to self-supply with cannabis in the Netherlands and the Czech Republic
The Good, the Bad, and the Ugly Weed”
With proliferating efforts to regulate the quality of cannabis on legalized markets, and recent discussions about drug quality assessment by darknet buyers, it seems timely to explore definitions of the quality of cannabis among consumers. An inductive analysis of in-depth interviews with people who had used cannabis in the past 12 months was conducted, which focused on the respondents’ subjective definitions and assessments of the quality of can…
Should I Buy or Should I Grow?” How drug policy institutions and drug market transaction costs shape the decision to self-supply with cannabis in the Netherlands and the Czech Republic
Qualitative research in Spanish cannabis social clubs
Assessing the concordance between illicit drug laws on the books and drug law enforcement
Online test purchased new psychoactive substances in 5 different European countries
Interpreting the Czech drug decriminalization
The burgeoning recognition and accommodation of the social supply of drugs in international criminal justice systems
Consumer agency in cannabis supply – Exploring auto-regulatory documents of the cannabis social clubs in Spain
Beyond Safer Injecting”—Health and Social Needs and Acceptance of Support among Clients of a Supervised Injecting Facility
Health and social issues in aging populations of people who inject drugs (PWID) tend to aggregate, despite risky injecting practices decreasing with age. Identifying needs and avenues of support is becoming increasingly important. We described the health and social situation among clients of a long-running supervised injecting facility (SIF) in Sydney, Australia. An interviewer-administered survey ( n = 182) assessed current housing status, emplo…
Learning from the past, looking to the future - Is there a place for injectable opioid treatment among Australia’s responses to opioid misuse
Overview of “home” cultivation policies and the case for community-based cannabis supply
How to ask about the use of new psychoactive substances to increase the validity of results in self‐report prevalence surveys
The Good, the Bad, and the Ugly Weed”
With proliferating efforts to regulate the quality of cannabis on legalized markets, and recent discussions about drug quality assessment by darknet buyers, it seems timely to explore definitions of the quality of cannabis among consumers. An inductive analysis of in-depth interviews with people who had used cannabis in the past 12 months was conducted, which focused on the respondents’ subjective definitions and assessments of the quality of can…
Monitoring drug trends in the digital environment–New methods, challenges and the opportunities provided by automated approaches
Opioid Agonist Maintenance Treatment Outcomes—The Optimus International Consensus Towards Evidence-Based and Patient-Centred Care, an Interim Report
Non-medical opioid use is a major public health concern causing high mortality. While opioid agonist maintenance treatment (OMT) is a key life-saving intervention, there is (a) no international consensus on opioid treatment outcomes and (b) few opioid treatment outcome studies include key (public) health outcomes, such as overdose or HIV/hepatitis C. We report the rationale and study protocol for, and preliminary results of, an ongoing internatio…
Hydromorphone Hopes
Outcomes of a community sector model of reintegration for people with complex needs
The Optimus International Consensus Guidance for Monitoring User-Reported Outcomes of Opioid Maintenance Treatment
Opioid use disorder is a major cause of drug-related harm and mortality. These can be reduced by expanded access to evidence-based and highly effective opioid agonist maintenance treatment or therapy (OMT). There is a lack of consensus on how to assess opioid use disorder treatment outcomes, and key health outcomes are often omitted. We report the results of a Delphi study to produce service user- and public health–centred international consensus…
Getting “The whole picture”
BACKGROUND: Several jurisdictions have pursued reforms that regulate cannabis production and/or sale for adult (non-medical) use. Looking at outcomes of such reforms across multiple jurisdictions may help to identify outcomes that are inherent to non-criminal cannabis supply, as well as provide insight into the outcomes of specific regulation models. METHODS: We identified nine indicators of cannabis policy outcomes and aggregated them into three…
Bridging the evidence and the politics
Supervised Injectable Opioid Treatment (SIOT) targets people experiencing opioid dependence who have not benefited from existing treatments. In this population, SIOT has been demonstrated to be efficacious and effective, yet this modality of treatment has only been taken up in a few countries. In this commentary we describe the socio-political context and history to the recent establishment of an implementation trial of injectable hydromorphone i…
Ex-Ante Analysis of the Costs and Benefits of Legalizing Cannabis Markets in the Czech Republic
Cannabis is the most commonly used illicit drug worldwide. In countries with repressive drug policies, the costs of its prohibition plausibly outweigh the benefits. We conduct a cost–benefit analysis of cannabis legalization and regulation in the Czech Republic, taking into consideration alternative scenarios designed using parameters from the known effects of cannabis legalization in selected U.S. states, Canada, and Uruguay. Our analysis focuse…
The new EU Drugs Strategy
Outreach mpox vaccination at sex-on-premises venues in Sydney
Mpox outreach vaccination done in collaboration between nurses and LGBTQI+ peer-workers at SOPVs proved feasible, acceptable, and beneficial in terms of reaching people who may be out of area and not routinely engaged with sexual health services. Models of care that circumnavigate traditional geographic and local health service barriers should be considered during outbreaks, particularly those that build on established rapport within the communit…
Medicine (14 works) · HIV, Drug Use, Sexual Risk (12 works) · Psychology (12 works) · Political science (10 works) · Business (9 works) · Cannabis (9 works) · Psychiatry (8 works) · Substance Abuse Treatment and Outcomes (8 works) · Cannabis and Cannabinoid Research (7 works) · Law (7 works)